Evidence map›Paper›PMID 36410621›Full record

ReviewAgeing research reviews2023

Major depression and the biological hallmarks of aging.

Erica C Lorenzo, George A Kuchel, Chia-Ling Kuo, Terrie E Moffitt, Breno S Diniz

Open access · hybridAbstract readReview
In one paragraph

Review in Ageing research reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Exploring blood-based biomarkers in late-life depression: Correlates of psychotherapeutic treatment outcomes.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Premature aging in serious mental illness.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  17. Article
  18. Review
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Erica C LorenzoUConn Center on Aging, University of Connecticut Health Center, Farmington, CT, USA.
George A KuchelUConn Center on Aging, University of Connecticut Health Center, Farmington, CT, USA.
Chia-Ling KuoDepartment of Public Health Sciences, University of Connecticut Health Center, Farmington, CT, USA.
Terrie E MoffittDepartment of Psychology and Neuroscience, Duke University, Durham, NC, USA; Social, Genetic, and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology, and Neuroscience, Kings College London, London, United Kingdom; PROMENTA Center, University of Oslo, Oslo, Norway.
Breno S DinizUConn Center on Aging, University of Connecticut Health Center, Farmington, CT, USA. Electronic address: diniz@uchc.edu.
UConn Health · USDuke University · US

Funding

Research Education ComponentP30AG067988 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Richard H Fortinsky, GEORGE A KUCHEL · 2021 to 2026
$9.5M
THE SENDEP STUDY: LINKING MOLECULAR SENESCENCE CHANGES TO DEPRESSION AND COGNITIVE IMPAIRMENT IN LATE LIFER01MH115953 · NIMH · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DINIZ, BRENO SATLER · 2019 to 2023
$3.0M
Validating a 3rd-generation methylation measure of accelerated aging: DunedinPoAm4xR01AG073207 · NIA · DUKE UNIVERSITY · PI CASPI, AVSHALOM, MOFFITT, TERRIE E · 2022 to 2025
$2.9M
EVALUATION OF MOLECULAR MECHANISMS OF TREATMENT RESPONSE IN LATE LIFE DEPRESSIONR01MH118311 · NIMH · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI DINIZ, BRENO SATLER, TSENG, GEORGE C. · 2019 to 2022
$2.0M
NIA NIH HHS P30 AG067988NIA NIH HHS R01 AG073207NIMH NIH HHS R01 MH115953NIMH NIH HHS R01 MH118311
6 · The paper itself

Abstract

Major depressive disorder (MDD) is characterized by psychological and physiological manifestations contributing to the disease severity and outcome. In recent years, several lines of evidence have suggested that individuals with MDD have an elevated risk of age-related adverse outcomes across the lifespan. This review provided evidence of a significant overlap between the biological abnormalities in MDD and biological changes commonly observed during the aging process (i.e., hallmarks of biological aging). Based on such evidence, we formulate a mechanistic model showing how abnormalities in the hallmarks of biological aging can be a common denominator and mediate the elevated risk of age-related health outcomes commonly observed in MDD. Finally, we proposed a roadmap for novel studies to investigate the intersection between the biology of aging and MDD, including the use of geroscience-guided interventions, such as senolytics, to delay or improve major depression by targeting biological aging.

Indexed as

Major Depressive DisorderAgingDepressionHumansLongevityBiology of agingCellularGeroscienceLate-life depressionMajor depressionSenescence

Identifiers

PMID36410621
PMCPMC9772222
OpenAlexW4309659052

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.